SU‑101 for the removal of pharmaceutical active compounds by the combination of adsorption/photocatalytic processes
Metadatos
Mostrar el registro completo del ítemAutor
Chacón García, Antonio J.; Rojas Macías, Sara; Grape, Erik Svensson; Salles, Fabrice; Willhammar, Tom; Inge, A. Ken; Pérez, Yolanda; Horcajada, PatriciaEditorial
Springer Nature
Materia
SU-101 Photoactive Bi-MOF Pharmaceutical active compounds
Fecha
2024-04-03Referencia bibliográfica
Chacón-García, A.J., Rojas, S., Grape, E.S. et al. SU-101 for the removal of pharmaceutical active compounds by the combination of adsorption/photocatalytic processes. Sci Rep 14, 7882 (2024). https://doi.org/10.1038/s41598-024-58014-w
Patrocinador
MOFSEIDON project PID2019-104228RB-100, MCI/AEI/FEDER, UE; Grant (RYC2021‐032522‐I) funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and for El FSE invierte en tu future; Swedish Foundation of Strategic Research (SSF); Formas—a Swedish Research Council for Sustainable Development (FORMAS, 2022-01270)Resumen
Pharmaceutical active compounds (PhACs) are some of the most recalcitrant water pollutants causing
undesired environmental and human effects. In absence of adapted decontamination technologies,
there is an urgent need to develop efficient and sustainable alternatives for water remediation.
Metal–organic frameworks (MOFs) have recently emerged as promising candidates for adsorbing
contaminants as well as providing photoactive sites, as they possess exceptional porosity and
chemical versatility. To date, the reported studies using MOFs in water remediation have been mainly
focused on the removal of a single type of PhACs and rarely on the combined elimination of PhACs
mixtures. Herein, the eco-friendly bismuth-based MOF, SU-101, has been originally proposed as an
efficient adsorbent-photocatalyst for the elimination of a mixture of three challenging persistent
PhACs, frequently detected in wastewater and surface water in ng L−1 to mg·L−1 concentrations: the
antibiotic sulfamethazine (SMT), the anti-inflammatory diclofenac (DCF), and the antihypertensive
atenolol (At). Adsorption experiments of the mixture revealed that SU-101 exhibited a great
adsorption capacity towards At, resulting in an almost complete removal (94.1 ± 0.8% for combined
adsorption) in only 5 h. Also, SU-101 demonstrated a remarkable photocatalytic activity under visible
light to simultaneously degrade DCF and SMT (99.6 ± 0.4% and 89.2 ± 1.4%, respectively). In addition,
MOF-contaminant interactions, the photocatalytic mechanism and degradation pathways were
investigated, also assessing the toxicity of the resulting degradation products. Even further, recycling
and regeneration studies were performed, demonstrating its efficient reuse for 4 consecutive cycles
without further treatment, and its subsequent successful regeneration by simply washing the material
with a NaCl solution.